Director, Global Forecasting

Role Description

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Director, Global Forecasting role requires strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning, and product and portfolio decisions. This role involves:

• Developing, refining, and communicating key strategic and revenue forecast assumptions and analyses.
• Working directly with Regional Forecasting leads to ensure consistency in forecast approach, assumptions, and analyses.
• Maintaining long-term forecast models and scenario plans for RevMed’s products across indications.
• Providing portfolio level views and analyses to support organizational decision making.
• Communicating and aligning key internal stakeholders around forecast assumptions.
• Understanding complex markets, disease states, competitive landscapes, and relevant market dynamics.
• Synthesizing and communicating necessary considerations to inform Global clinical development plans.
• Exhibiting analytical rigor in the valuation of business opportunities and quantification of risk.
• Participating in cross-functional teams to gather input for functional activities.
• Partnering closely with other Insights and Analytics functions to inform the forecast.
• Working closely with Pipeline Marketing, Clinical Development, Portfolio Management, and Medical Affairs.
• Maintaining an in-depth understanding of Revolution Medicines’ diverse product offerings and market dynamics.
• Collaborating with vendor partners to manage various deliverables and analyses.

Qualifications

• Bachelor's degree required (MBA preferred).
• 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role.
• 6+ years of experience in a related analytics/forecasting role.
• Experience developing long-range patient-based forecasts for oncology products.
• Experience supporting pipeline and portfolio decision making.
• Track record of being a collaborative team player.
• Strong problem solver with experience leveraging research and analytical vendors.
• Demonstrated ability to influence senior management and key business partners.
• Proven experience in a smaller, rapidly growing company.
• Excellent organizational skills and ability to prioritize effectively.
• Strong interpersonal skills including verbal and written communication.
• Entrepreneurial mindset with a passion for helping cancer patients.

Requirements

• 8+ years of experience in patient-based forecasting with a focus in Oncology.
• Experience with targeted oncolytics.
• Experience working with Global teams.
• Demonstrated ability to synthesize complex information and influence decision-making at the executive level.

Benefits

• Competitive cash compensation.
• Robust equity awards.
• Strong benefits.
• Significant learning and development opportunities.

Company Description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.